Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_assertion description "[Erlotinib is an epidermal growth factor receptor tyrosine-kinase inhibitor (EGFR-TKI), used for the treatment of non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_assertion evidence source_evidence_literature NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_assertion SIO_000772 25129367 NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_assertion wasDerivedFrom befree-2016 NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_assertion wasGeneratedBy ECO_0000203 NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.
- befree-2016 importedOn "2016-02-19" NP1211290.RAiQ8qdfwOnP2S1RwF6Emxw5iNHD5olexub3QtYx6zL64130_provenance.